Speciality: Oncology
Description:
Welcome to this insightful discussion featuring Dr. Vamshi Krishna M, a renowned expert in oncology, as he delves into the unmet needs and challenges in the current care of ALK-positive Non-Small Cell Lung Cancer (NSCLC). In this video, Dr. Vamshi highlights the significant gaps in treatment options, including resistance mechanisms, limited access to next-generation therapies, and the need for personalized approaches to improve patient outcomes. He emphasizes the importance of early detection, advanced diagnostics, and the development of novel therapeutic strategies to address these pressing issues.
Dr. Vamshi further explores the real-world challenges faced by clinicians managing ALK-positive NSCLC, such as treatment sequencing, managing side effects, and optimizing therapy for better survival rates. He discusses the evolving landscape of targeted therapies and immunotherapy while underscoring the necessity for more clinical trials and collaborative research to bridge existing gaps. His expertise provides valuable perspectives for oncologists, researchers, and healthcare professionals striving to enhance patient care in this niche yet critical area of lung cancer.
Don’t miss this compelling discussion that sheds light on the future directions and unmet needs in ALK-positive NSCLC. Stay tuned for more expert insights from Dr. Vamshi Krishna M and other leading voices in oncology. Be sure to watch till the end and subscribe for updates on upcoming videos that continue to explore groundbreaking advancements in cancer care.
See More Webinars @ Hidoc Webinars
1.
A novel test shows promise for finding cervical adenocarcinoma, which is difficult to find.
2.
Researchers publish action plan to address appendiceal cancer enigmas
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
Underprescribed for Alcohol Use Disorder is pharmacotherapy.
5.
Cancer "Tidal Wave" Prediction: Not Cigarette-Based, Either! Wary Stories Regarding Cannabis and Cancer.
1.
Unveiling the Mystery of Echinocyte: A Closer Look at the Unique Red Blood Cell
2.
The Bloodstream Compass: A Comparative Clinical Review of Liquid Biopsy and AI in Predictive Oncology
3.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
4.
Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases
5.
Optimizing Oncology Practice Revenue: Billing Software, Payer Trends, and Financial Navigation Tools
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
2.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
4.
A New Era in Managing Cancer-Associated Thrombosis
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation